Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
27
CYIO Quote, Financials, Valuation and Earnings
Last price:
$0.0000
Seasonality move
:
99.4%
Day range:
$0.0024 - $0.0029
52-week range:
$0.0023 - $0.0099
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.06x
P/B ratio:
1.09x
Volume:
3.1M
Avg. volume:
1.6M
1-year change:
-69.51%
Market cap:
$769K
Revenue:
$8M
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, CYIOS Corp. has -- downside to fair value with a price target of -- per share.
CYIO vs. S&P 500
-
Over the past 5 trading days, CYIOS Corp. has underperformed the S&P 500 by -25.45% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
CYIOS Corp. does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
CYIOS Corp. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter CYIOS Corp. reported revenues of --.
Earnings Growth
-
CYIOS Corp. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter CYIOS Corp. reported earnings per share of --.
Enterprise value:
2.9M
EV / Invested capital:
--
Price / LTM sales:
0.06x
EV / EBIT:
--
EV / Revenue:
0.28x
PEG ratio (5yr expected):
-0.01x
EV / Free cash flow:
-20.33x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $153.4K | $37K | $10.5M | -- | $2.5M | |
| Gross Profit | $151.4K | -$1.9K | $822.6K | -$1.9K | $288.4K | |
| Operating Income | -$1M | -$486.1K | -$223.7K | -$113.2K | -$144.3K | |
| EBITDA | -$1M | -$484.2K | -$223.7K | -$111.3K | -$144.3K | |
| Diluted EPS | -$0.01 | -$0.00 | -$0.00 | -$0.00 | -$0.00 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $383.8K | $351.5K | $72.3K | $178.1K | $670.9K | |
| Total Assets | $383.4K | $1.9M | $1M | $1.1M | $995.9K | |
| Current Liabilities | $194.5K | $2M | $2.5M | $2.4M | $3M | |
| Total Liabilities | $933.7K | $2M | $2.5M | $2.4M | $3M | |
| Total Equity | -$550.3K | -$153.6K | -$1.4M | -$1.3M | -$2.2M | |
| Total Debt | $739.2K | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -$168.9K | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | $146.4K | |
| Free Cash Flow | -- | -- | -- | -- | -$168.9K | |
CYIO
Sector
Market Cap
$769K
--
Price % of 52-Week High
25.25%
--
Dividend Yield
0%
--
Shareholder Yield
--
--
1-Year Price Total Return
-69.51%
--
Beta (5-Year)
0.430
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.0031
200-day SMA
Sell
Level
$0.0049
Bollinger Bands (100)
Sell
Level
0.004 - 0.004
Chaikin Money Flow
Buy
Level
107.8M
20-day SMA
Sell
Level
$0.0035
Relative Strength Index (RSI14)
Sell
Level
35.4182
ADX Line
Sell
Level
18.2514
Williams %R
Buy
Level
-89.4737
50-day SMA
Sell
Level
$0.0039
MACD (12, 26)
Sell
Level
-0.0002
25-day Aroon Oscillator
Sell
Level
-88
On Balance Volume
Neutral
Level
21.3M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-42.163)
Sell
CA Score
(Annual)
Level (-8.464)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (1)
Sell
Ohlson Score
Level (26.6779)
Buy
Piotroski F Score
(Annual)
Level (4)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
CYIOS Corp. is a holding company, which engages in development and marketing of specialty branded products in the Health and Wellness markets. It operates through the Health and Wellness segment. The company was founded by Timothy W. Carnahan in 1994 and is headquartered in Deerfield Beach, FL.
Stock Forecast FAQ
In the current month, CYIO has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CYIO average analyst price target in the past 3 months is --.
-
Where Will CYIOS Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that CYIOS Corp. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About CYIOS Corp.?
Analysts are divided on their view about CYIOS Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that CYIOS Corp. is a Sell and believe this share price will rise from its current level to --.
-
What Is CYIOS Corp.'s Price Target?
The price target for CYIOS Corp. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CYIO A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for CYIOS Corp. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of CYIO?
You can purchase shares of CYIOS Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase CYIOS Corp. shares.
-
What Is The CYIOS Corp. Share Price Today?
CYIOS Corp. was last trading at $0.0000 per share. This represents the most recent stock quote for CYIOS Corp.. Yesterday, CYIOS Corp. closed at $0.0025 per share.
-
How To Buy CYIOS Corp. Stock Online?
In order to purchase CYIOS Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get CYIO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CYIO
Sector
P/E ratio
--
--
PEG ratio
-0.01x
--
P/B ratio
1.09x
--
Price / LTM sales
0.06x
--
Growth Metrics
CYIO
Sector
Revenue growth
--
--
Earnings growth
--
--
Revenue (5-year growth)
--
--
Earnings forecast
--
--
Profitability
CYIO
Sector
Profitability FY 2024
$534.2K
--
Return on invested capital
--
--
Return on assets
--
--
Return on equity
--
--
Earnings Date
Last Earnings Date
Dec
21
Next Earnings Date
Dec
21
Estimated Next Earnings Date
Mar
22
Balance Sheet
CYIO
Sector
Total cash
--
--
Short term investments
--
--
Total assets
$959.2K
--
Long term debt
--
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
